Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher Shares of TransCode Therapeutics plunged in premarket trading Tuesday following a steep run-up in its stock price on Monday, after the RNA...
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...
By Ben Glickman Shares of TransCode Therapeutics jumped Monday after reporting positive study results for its lead cancer treatment candidate. The stock was...
TransCode Therapeutics, Inc. (RNAZ) shares are surging more than 163 percent on Monday morning trade after the company announced positive results with its TTX-MC138, in murine models bearing human glioblastoma multiforme or GBM tumors.